Akesobio set to launch $300m Hong Kong IPO

By Jonathan Breen
08 Apr 2020

Chinese biopharmaceuticals firm Akesobio is preparing to launch bookbuilding for its IPO next week, according to a source close to the deal.

JP Morgan and Morgan Stanley are running the show as the sponsors. The duo kicked off pre-marketing for the deal this week and are set to open books in the week of April 13.

The listing is expected to raise about $300m, said the source.

Akesobio is a clinical-state biopharmaceuticals ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.